Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

The Chemotherapy-Free Combination of Vemurafenib and Rituximab Produces Deep and Durable Responses in Relapsed or Refractory Hairy Cell Leukemia (HCL) Patients

Enrico Tiacci, Luca De Carolis, Francesco Zaja, MD, Monia Capponi, Achille Ambrosetti, Eugenio Lucia, Agostino Antolino, Alessandro Pulsoni, MD, Samantha Ferrari, MD, Pier Luigi Zinzani, MD, Luigi Rigacci, Gianluca Gaidano, MD PhD, Roberta Della Seta, Natalia Frattarelli, Paolo Falcucci, Giuseppe Visani, Robin Foà, MD, Brunangelo Falini, MD

Blood (2017) 130 (Supplement 1): 409.

https://doi.org/10.1182/blood.V130.Suppl_1.409.409

Published: 2017

Journal Articles

Vemurafenib Plus Rituximab in Hairy Cell Leukemia: A Promising Chemotherapy-Free Regimen for Relapsed or Refractory Patients

Enrico Tiacci, Luca De Carolis, Francesco Zaja, Achille Ambrosetti, MD, Eugenio Lucia, Agostino Antolino, Alessandro Pulsoni, MD, Samantha Ferrari, MD, Pier Luigi Zinzani, Gianluca Gaidano, MD PhD, Robin Foà, Brunangelo Falini

Blood (2016) 128 (22): 1214.

https://doi.org/10.1182/blood.V128.22.1214.1214

Published: 2016

Journal Articles

CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations

Massimiliano Bonifacio, Rachele Montemezzi, Alice Parisi, Giovanna De Matteis, Luigi Scaffidi, Giuseppe Lippi, Marco Chilosi, Giovanni Pizzolo, Mauro Krampera, Achille Ambrosetti, MD

Blood (2016) 128 (22): 3122.

https://doi.org/10.1182/blood.V128.22.3122.3122

Published: 2016

Journal Articles

Effects on Survival and Neurocognitive Functions of Whole-Brain Radiotherapy (WBRT) and Autologous Stem Cell Transplantation (ASCT) as Consolidation Options after High-Dose Methotrexate-Based Chemoimmunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma (PCNSL): Results of the Second Randomization of the IELSG32 Trial

Andrés J.M. Ferreri, MD, Kate Cwynarski, MBBS, FRPATH, PhD, Elisa Jacobsen Pulczynski, MD, Christopher P. Fox, MBChB, PhD, Elisabeth Schorb, MD, Paul La Rosée, MD, Mascha Binder, MD, Alberto Fabbri, MD, Valter Torri, MD, Eleonora Minacapelli, MD, Monica Falautano, MD, Fiorella Ilariucci, MD, Achille Ambrosetti, MD, Alexander Röth, MD, Claire Jane Hemmaway, MD, Peter M Johnson, MA, MD, Kim Linton, MBChB, MRCP, PhD, Tobias Pukrop, MD, Jette Sonderskov Gorlov, MD, Monica Balzarotti, MD, Georg Hess, MD, Ulrich Keller, MD, Stephan Stilgenbauer, MD, Jens P. Panse, MD, Alessandra Tucci, MD, Lorella Orsucci, MD, Francesco Pisani, MD, Alessandro Levis, MD, Stefan W. Krause, MD, Hans-Joachim Schmoll, MD PhD, Bernd Hertenstein, MD, Mathias Rummel, MD PhD, Jeffery Smith, MD, Michael Pfreundschuh, MD, PhD, Giuseppina Cabras, MD, Francesco Angrilli, MD, Maurilio Ponzoni, MD, Martina Deckert, MD, Letterio S. Politi, MD, Jurgen Finke, MD, Michele Reni, MD, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, MD

Blood (2016) 128 (22): 511.

https://doi.org/10.1182/blood.V128.22.511.511

Published: 2016

Journal Articles

Similar Efficacy of Dasatinib and Nilotinib As Second-Line Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Failing Imatinib: A Retrospective, Real-Life Study

Blood (2016) 128 (22): 5434.

https://doi.org/10.1182/blood.V128.22.5434.5434

Published: 2016

Journal Articles

Predictive Factors of Stable Deep Molecular Response in Chronic Myeloid Leukemia Patients Treated with Imatinib Standard Dose: A Study from the Gruppo Triveneto LMC

Massimiliano Bonifacio, MD, Luigi Scaffidi, Gianni Binotto, Federico De Marchi, Elena Maino, Elisabetta Calistri, Angela Bonalumi, Luca Frison, Luciana Marin, Marta Medeot, Giovanna De Matteis, Renato Fanin, Gianpietro Semenzato, Achille Ambrosetti, Mario Tiribelli, MD

Blood (2015) 126 (23): 597.

https://doi.org/10.1182/blood.V126.23.597.597

Published: 2015

Journal Articles

Efficacy and Safety of the BRAF Inhibitor Vemurafenib in Hairy Cell Leukemia Patients Refractory to or Relapsed after Purine Analogs: A Phase-2 Italian Clinical Trial

Enrico Tiacci, Luca De Carolis, Pier Luigi Zinzani, Alessandro Pulsoni, Francesco Zaja, Michele Cimminiello, Achille Ambrosetti, Davide Rossi, Giovanna Motta, Marzia Varettoni, Vincenzo Fraticelli, Angelo Michele Carella, Antonella Anastasia, Pietro Leoni, Alessandro Rambaldi, Stefano Aldo Pileri, Robin Foà, Brunangelo Falini

Blood (2014) 124 (21): 150.

https://doi.org/10.1182/blood.V124.21.150.150

Published: 2014

Journal Articles

Genomic Analisys of Notch Mutations in a Case of Alagille Syndrome with Acute Lymphoblastic Leukemia

Simona Bernardi, Paola Tononi, Sergio Marin Vargas, Giulio Bassi, MSc,PhD, Paul Takam Kamga, Omar Perbellini, MD, Achille Ambrosetti, Vittorio Meneghini, Luigi Scaffidi, Giovanni Martinelli, MD, Ilaria Iacobucci, PhD, Giovanni Pizzolo, MD, Massimo Delledonne, PhD, Mauro Krampera, MD PhD

Blood (2014) 124 (21): 5338.

https://doi.org/10.1182/blood.V124.21.5338.5338

Published: 2014

Journal Articles

Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasms

Pontus Lundberg, Ronny Nienhold, Achille Ambrosetti, Francisco Cervantes, Manuel M. Pérez-Encinas, Radek C. Skoda

Blood (2014) 123 (17): 2744–2745.

https://doi.org/10.1182/blood-2014-01-550863

Published: 2014

Journal Articles

Genomic Analysis Of Notch Mutations In a Case Of Alagille Syndrome With Acute Lymphoblastic Leukemia

Simona Bernardi, Paola Tononi, Sergio Marin Vargas, Giulio Bassi, Achille Ambrosetti, Vittorio Meneghini, Luigi Scaffidi, Giovanni Martinelli, MD, Ilaria Iacobucci, PhD, Giovanni Pizzolo, MD, Massimo Delledonne, Mauro Krampera, MD, PhD

Blood (2013) 122 (21): 4992.

https://doi.org/10.1182/blood.V122.21.4992.4992

Published: 2013

Journal Articles

Bendamustine in Chronic Lymphocytic Leukemia (CLL): Outcome According to Different Clinical and Biological Prognostic Factors in Everyday Practice

Francesco Zaja, Michael Mian, Carlo Visco, Cinzia Sissa, Ilaria Nichele, Monica Castelli, Achille Ambrosetti, Simona Puglisi, Renato Fanin, Sergio Cortelazzo, MD, Giovanni Pizzolo, MD, Livio Trentin, MD, Francesco Rodeghiero, Rossella Paolini, Paolo Vivaldi, Rosaria Sancetta, Gianpietro Semenzato

Blood (2012) 120 (21): 3922.

https://doi.org/10.1182/blood.V120.21.3922.3922

Published: 2012

Journal Articles

Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF -V600E mutation

Enrico Tiacci, Gianluca Schiavoni, Francesco Forconi, Alessia Santi, Livio Trentin, Achille Ambrosetti, Debora Cecchini, Elisa Sozzi, Paola Francia di Celle, Cristiana Di Bello, Alessandro Pulsoni, Robin Foà, Giorgio Inghirami, Brunangelo Falini

Blood (2012) 119 (1): 192–195.

https://doi.org/10.1182/blood-2011-08-371179

Published: 2012

Journal Articles

Rituximab Plus Chlorambucil As Initial Treatment for Elderly Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Pre-Treatment Biological Characteristics and Gene Expression Patterns on Response to Treatment

Blood (2011) 118 (21): 294.

https://doi.org/10.1182/blood.V118.21.294.294

Published: 2011

Journal Articles

A Phase II Study of Chlorambucil Plus Rituximab Followed by Maintenance Versus Observation In Elderly Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results of the First Interim Analysis

Blood (2010) 116 (21): 2462.

https://doi.org/10.1182/blood.V116.21.2462.2462

Published: 2010

Journal Articles

Prognostic Models to Predict Survival In Indolent and Aggressive Non-Hodgkin's Lymphomas Associated with Hepatitis C Virus Infection: a Multicenter Italian Study on 1,043 Patients.

Michele Merli, MD, Michele Spina, MD, Stefano Luminari, MD, Claudia Basilico, MD, Clara Targhetta, MD, Carlo Visco, MD, Alessandro Levis, MD, Davide Rossi, MD, Alfonso Maria D'Arco, MD, Luigi Rigacci, MD, Achille Ambrosetti, MD, Pellegrino Musto, MD, Alessandra Tucci, MD, Annalisa Chiappella, MD, Andrea Ferrario, MD, Sara Rattotti, MD, Virginia Valeria Ferretti, PhD, Cristiana Pascutto, PhD, Luca Arcaini, MD

Blood (2010) 116 (21): 2821.

https://doi.org/10.1182/blood.V116.21.2821.2821

Published: 2010

Journal Articles

The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)

Blood (2008) 112 (11): 3608.

https://doi.org/10.1182/blood.V112.11.3608.3608

Published: 2008

Journal Articles

Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia

Carlo Visco, Marco Ruggeri, Maria Laura Evangelista, Roberto Stasi, Roberta Zanotti, Ilaria Giaretta, Achille Ambrosetti, Domenico Madeo, Giovanni Pizzolo, Francesco Rodeghiero

Blood (2008) 111 (3): 1110–1116.

https://doi.org/10.1182/blood-2007-09-111492

Published: 2008

Journal Articles

Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

Marco Vignetti, Paola Fazi, Giuseppe Cimino, Giovanni Martinelli, Francesco Di Raimondo, Felicetto Ferrara, Giovanna Meloni, Achille Ambrosetti, Giovanni Quarta, Livio Pagano, Giovanna Rege-Cambrin, Loredana Elia, Raffaello Bertieri, Luciana Annino, Robin Foà, Michele Baccarani, Franco Mandelli

Blood (2007) 109 (9): 3676–3678.

https://doi.org/10.1182/blood-2006-10-052746

Published: 2007

Includes: Supplemental data

Journal Articles

Relationship between Autoimmune Phenomena and Disease Stage and Therapy in B-Cell Chronic Lymphocytic Leukaemia.

Wilma Barcellini, MD, Silvana Capalbo, MD, Rosa M. Agostinelli, MD, Francesca R. Mauro, MD, Achille Ambrosetti, MD, Rossella Calori, MD, Agostino Cortelezzi, MD, Luca Laurenti, MD, Enrico M. Pogliani, MD, Paola Pedotti, MD, Vincenzo Liso, MD, Franco Mandelli, MD, Alberto Zanella, MD

Blood (2006) 108 (11): 4929.

https://doi.org/10.1182/blood.V108.11.4929.4929

Published: 2006

Journal Articles

Autoimmune Thrombocytopenic Purpura Complicating Chronic Lymphocytic Leukemia: Analysis of 60 Patients.

Carlo Visco, Roberto Stasi, Marco Ruggeri, Achille Ambrosetti, Stefania Fortuna, Francesco Frattini, Ilaria Giaretta, Roberta Zanotti, Domenico Madeo, Giovanni Pizzolo, Francesco Rodeghiero

Blood (2006) 108 (11): 4932.

https://doi.org/10.1182/blood.V108.11.4932.4932

Published: 2006

NARROW

The Chemotherapy-Free Combination of Vemurafenib and Rituximab Produces Deep and Durable Responses in Relapsed or Refractory Hairy Cell Leukemia (HCL) Patients

Vemurafenib Plus Rituximab in Hairy Cell Leukemia: A Promising Chemotherapy-Free Regimen for Relapsed or Refractory Patients

CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations

Similar Efficacy of Dasatinib and Nilotinib As Second-Line Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Failing Imatinib: A Retrospective, Real-Life Study

Predictive Factors of Stable Deep Molecular Response in Chronic Myeloid Leukemia Patients Treated with Imatinib Standard Dose: A Study from the Gruppo Triveneto LMC

Efficacy and Safety of the BRAF Inhibitor Vemurafenib in Hairy Cell Leukemia Patients Refractory to or Relapsed after Purine Analogs: A Phase-2 Italian Clinical Trial

Genomic Analisys of Notch Mutations in a Case of Alagille Syndrome with Acute Lymphoblastic Leukemia

Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasms

Genomic Analysis Of Notch Mutations In a Case Of Alagille Syndrome With Acute Lymphoblastic Leukemia

Bendamustine in Chronic Lymphocytic Leukemia (CLL): Outcome According to Different Clinical and Biological Prognostic Factors in Everyday Practice

Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF -V600E mutation

Rituximab Plus Chlorambucil As Initial Treatment for Elderly Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Pre-Treatment Biological Characteristics and Gene Expression Patterns on Response to Treatment

A Phase II Study of Chlorambucil Plus Rituximab Followed by Maintenance Versus Observation In Elderly Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results of the First Interim Analysis

Prognostic Models to Predict Survival In Indolent and Aggressive Non-Hodgkin's Lymphomas Associated with Hepatitis C Virus Infection: a Multicenter Italian Study on 1,043 Patients.

The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)

Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia

Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

Relationship between Autoimmune Phenomena and Disease Stage and Therapy in B-Cell Chronic Lymphocytic Leukaemia.

Autoimmune Thrombocytopenic Purpura Complicating Chronic Lymphocytic Leukemia: Analysis of 60 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only